About Sancilio Pharmaceuticals Private Limited
Data last updated:
Sancilio Pharmaceuticals Private Limited was a foreign private limited company based in Thane, Maharashtra, India, operated as a subsidiary of Sancilio And Company Inc. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2014.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2014FTC254795. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Carolyn Alex Sancilio and Frederick Dominick Sancilio.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Thane, Maharashtra.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.65 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹5.66 Lakh (net margin 3.4%) and EBITDA of ₹8.48 Lakh (EBITDA margin 5.1%).
The company was associated with 1 brand: Sancilio & Company.
The last known website on record is sancilio.com.
Company details
Contact details
Sancilio Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is sancilio.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address301 3rd Floor Arcadia Hiranandani Estate Patlipada Behind Municipal Commissioners, Bunglow, Thane, Maharashtra, India – 400607
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sancilio Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sancilio Pharmaceuticals operates one associated brand: Sancilio & Company. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Innovative drug candidates are developed using proprietary Advanced Lipid Technologies. | sancilio.com |
Business activity
The main business activity of Sancilio Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Sancilio Pharmaceuticals Private Limited, buy the company report.
Financials of Sancilio Pharmaceuticals Private Limited
FY 2017 filings availableSancilio Pharmaceuticals Private Limited reported revenue of ₹1.65 Cr (up 9% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. EBITDA fell 31% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.65 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹8.48 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹5.66 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.1% | ||
| Net Profit Margin | 3.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sancilio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sancilio Pharmaceuticals Private Limited
Sancilio Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Carolyn Alex Sancilio | Director | 21 Mar 2014 | 12 Years 7 Months | As last reported |
| Frederick Dominick Sancilio | Director | 21 Mar 2014 | 12 Years 7 Months | As last reported |
| Nirmalya Chatterjee | Director | 21 Mar 2014 | 12 Years 7 Months | As last reported |
Auditor
Sancilio Pharmaceuticals Private Limited is audited by C V K & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C V K & ASSOCIATES | FY 2017 | 101745W |
Shareholding
The shareholding of Sancilio Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sancilio Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sancilio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sancilio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sancilio Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sancilio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sancilio Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Daren Nae Graham ceased to be Director on 02 Dec 2015.
News
Frequently asked questions
Sancilio Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sancilio Pharmaceuticals was a foreign private limited company based in Thane, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2014 and is registered under CIN U74120MH2014FTC254795. The company has been struck off by the Registrar of Companies and is no longer operational.
Sancilio Pharmaceuticals had 3 directors:
- Carolyn Alex Sancilio - Director
- Frederick Dominick Sancilio - Director
- Nirmalya Chatterjee - Director
The CIN (Corporate Identification Number) of Sancilio Pharmaceuticals is U74120MH2014FTC254795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sancilio Pharmaceuticals is at 301 3rd Floor Arcadia Hiranandani Estate Patlipada Behind Municipal Commissioners, Bunglow, Thane, Maharashtra, India – 400607.
Sancilio Pharmaceuticals was incorporated on 21 March 2014. It is registered with the Registrar of Companies, Mumbai.
Sancilio Pharmaceuticals can be reached through the website sancilio.com. Its registered office is in Thane, Maharashtra, India.
The latest financial statements of Sancilio Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
No. Sancilio Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Sancilio Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
